HealthPrize Teams Up with RealAge to Improve Adherence High Engagement in HealthPrize’s Reward Program Among Asthma/COPD PatientsClick Here for Additional Resources
In the six-month asthma and chronic obstructive pulmonary disease (COPD) pilot, 282 adult patients engaged with HealthPrize’s online and mobile platform that leverages rewards, behavioral economics and gaming dynamics to motivate people to stick with their prescription medications.
Aired LIVE on: Tuesday, February 28, 2012
You may also visit this Pharma Marketing Talk Segment Page to listen to the audio podcast.
This show and ALL Pharma Marketing Talk shows are available as podcasts via PMT on iTunes (FREE!).
According to a 2008 study of 1,812 patients with asthma or COPD, only 13 percent of patients refilled their medication often enough to allow for continuous coverage. Given that daily maintenance inhaler use is critical to preventing exacerbations, emergency room visits, and hospitalizations, innovative solutions are required to improve outcomes in this population.
HealthPrize Technologies, LLC, a leading innovator in the medication adherence space, in partnership with RealAge – a leading health and wellness site – completed a six-month asthma and chronic obstructive pulmonary disease (COPD) pilot that tested engagement with HealthPrize’s online and mobile platform that leverages rewards, behavioral economics and gaming dynamics to motivate people to stick with their prescription medications.
A total of 282 adult patients, with a mean age of 53.5, participated in the HealthPrize program, which involved earning points for a number of activities: self-reporting medication taking, completing weekly educational quizzes and surveys, and opening daily educational “Fortune Cookies.” Points were then redeemed in the Rewards Mall for e-certificates and merchandise. Participants also engaged in a monthly Leaderboard competition and weekly PowerPill sweepstakes.Questions/Topics Discussed
- How does the HealthPrize system work?
- How do you differentiate yourself from other adherence approaches?
- Why did you choose Asthma/COPD patients as the first group for a pilot?
- Please review the patient reactions to this program. How did patients rate the program overall? Did it improve adherence as you expected?
- Which parts of the program did these patients like the most?
- Are you planning to do other pilor programs for patients with other medical conditions? How will these programs differ from the COPD program?
Tom Kottler is co-founder and CEO of HealthPrize, the fourth start-up venture he has founded or been associated with as part of the initial management team. Tom’s first start-up is called MedAptus, a healthcare IT company in Boston that creates and sells software systems for physician practice groups. After leaving MedAptus, Tom joined the management team of Celadon Science, a venture developing cell-based wound care technology with technology licensed from the cell biology department at the Harvard Medical School. Tom’s third venture is called VeinAid, which is developing non-invasive medical technology to treat varicose veins, and is based on patents with Tom as named inventor.
Katrina S. Firlik is the author of Another Day in the Frontal Lobe: A Brain Surgeon Exposes Life on the Inside, published by Random House and reviewed by The New York Times, The Los Angeles Times, and O Magazine. She enjoys conveying medical concepts to the public and has appeared on CNN, Fox, and MSNBC as a commentator on a variety of medical issues. She is also an inventor of a brain stimulation device designed to enhance recovery after stroke.
Katrina did her undergraduate studies at Cornell University, with a major in cultural anthropology. She attended medical school at Case Western Reserve University, and did her neurosurgery residency at the University of Pittsburgh, one the largest neurosurgery centers in the country, where she was the first woman ever accepted to the program. Katrina also completed a specialty fellowship in epilepsy surgery at Yale University.